Bicara Therapeutics logo

Bicara Therapeutics Share Price (NASDAQ: BCAX)

$11.93

0.02

(0.17%)

Last updated on

Check the interactive Bicara Therapeutics Stock chart to analyse performance

Bicara Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$11.74
    Today's High:$11.99

    Day's Volatility :2.09%

  • 52 Weeks Low:$7.80
    52 Weeks High:$28.09

    52 Weeks Volatility :72.23%

Bicara Therapeutics Stock Returns

PeriodBicara TherapeuticsIndex (Russel 2000)
3 Months
20.51%
0.0%
6 Months
-6.06%
0.0%
1 Year
-49.04%
0.0%
3 Years
-49.04%
-4.7%

Bicara Therapeutics Key Stats

Check Bicara Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$11.91
Open
$11.74
Today's High
$11.99
Today's Low
$11.74
Market Capitalization
$649.8M
Today's Volume
$189.3K
52 Week High
$28.09
52 Week Low
$7.8
Revenue TTM
$0.0
EBITDA
$-121.0M
Earnings Per Share (EPS)
$-4.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-32.71%

Stock Returns calculator for Bicara Therapeutics Stock including INR - Dollar returns

The Bicara Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bicara Therapeutics investment value today

Current value as on today

₹56,245

Returns

₹43,755

(-43.75%)

Returns from Bicara Therapeutics Stock

₹49,039 (-49.04%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Bicara Therapeutics Stock

-29%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Bicara Therapeutics Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Bicara Therapeutics Stock

Rating
Trend

Bicara Therapeutics Share Price Target

What analysts predicted

Upside of 176.61%

Target:

$33.00

Current:

$11.93

Bicara Therapeutics share price target is $33.00, a slight Upside of 176.61% compared to current price of $11.93 as per analysts' prediction.

Bicara Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, BCAX stock has moved up by 29.0%

Bicara Therapeutics Technicals Summary

Sell

Neutral

Buy

Bicara Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Bicara Therapeutics Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Bicara Therapeutics logo
7.38%
-6.06%
-49.04%
-49.04%
-49.04%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Bicara Therapeutics

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Organization
Bicara Therapeutics
Employees
55
CEO
Dr. Claire Mazumdar Clemon M.B.A., Ph.D.
Industry
Miscellaneous

Key Management of Bicara Therapeutics

NameTitle
Dr. Claire Mazumdar Clemon M.B.A., Ph.D.
CEO & Director
Mr. Ryan Cohlhepp Pharm.D.
President, COO & Director
Mr. Ivan Hyep M.B.A.
Chief Financial Officer
Ms. Lara S. Meisner J.D.
Chief Legal Officer & Corporate Secretary
Ms. Rachel Salazar
SVP of R&D Strategy and Operations
Ms. Sathish Hasige Ph.D.
Senior VP and Head of Technical Operations & Supply Chain
Dr. David Raben M.D.
Chief Medical Officer
Ms. Angela Windt
VP & Head of Regulatory Affairs
Dr. Jeltje Schulten M.B.A., M.D.
Senior Vice President of Clinical & Medical Affairs
Mr. Jean-Paul Rodrique
Senior VP & Global Head of Quality Assurance

Important FAQs about investing in BCAX Stock from India :

What is Bicara Therapeutics share price today?

Bicara Therapeutics share price today is $11.93 as on at the close of the market. Bicara Therapeutics share today touched a day high of $11.99 and a low of $11.74.

What is the 52 week high and 52 week low for Bicara Therapeutics share?

Bicara Therapeutics share touched a 52 week high of $28.09 and a 52 week low of $7.80. Bicara Therapeutics stock price today i.e. is closed at $11.93, lower by 57.53% versus the 52 week high.

How to invest in Bicara Therapeutics Stock (BCAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bicara Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bicara Therapeutics Shares that will get you 0.1257 shares as per Bicara Therapeutics share price of $11.93 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bicara Therapeutics Stock (BCAX) from India?

Indian investors can start investing in Bicara Therapeutics (BCAX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Bicara Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Bicara Therapeutics share’s latest price of $11.93 as on August 30, 2025 at 1:29 am IST, you will get 0.8382 shares of Bicara Therapeutics. Learn more about fractional shares .

What are the returns that Bicara Therapeutics has given to Indian investors in the last 5 years?

Bicara Therapeutics stock has given -49.04% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?